ingsworth MA, Thayer SP, Ahlquist DA, Andersen DK, et al. Early detection of sporadic pancreatic cancer: summative review. Pancreas. 2015;44:693–712.CrossRefGoogle Scholar
- 4.CrossRefGoogle Scholar
- 5.Lipner MB, Yeh JJ. Sequencing pancreatic juice: squeezing the most out of surveillance. Clin Cancer Res. 2018.Google Scholar
- 6.Oldfield LE, Connor AA, Gallinger S. Molecular events in the natural history of pancreatic cancer. Trends Cancer. 2017;3:336–46.CrossRefGoogle Scholar
- 7.Murphy SJ, Hart SN, Lima JF, Kipp BR, Klebig M, Winters JL, et al. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor. Gastroenterology. 2013;145:1098–109 e1.CrossRefGoogle Scholar
- 8.The Cancer Genome Atlas Research Network. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell. 2017;32:185–203.e13.Google Scholar
- 9.Shi C, Fukushima N, Abe T, Bian Y, Hua L, Wendelburg BJ, et al. Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection. Cancer Biology & Therapy. 2008;7:353–60.CrossRefGoogle Scholar
- 10.Kanda M, Knight S, Topazian M, Syngal S, Farrell J, Lee J, et al. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut. 2013;62:1024–33.CrossRefGoogle Scholar
- 11. Clinical Gastroenterology and Hepatology. 2013;11:719–730 e5.Google Scholar
- 12.Eshleman JR, Norris AL, Sadakari Y, Debeljak M, Borges M, HarringtonGoogle Scholar
- 13.CrossRefGoogle Scholar
- 14.Suenaga M, Yu J, Shindo K, Tamura K, Almario JAN, Zaykoski CM, et al. Pancreatic juice mutation concentrations can help predict the grade of dysplasia in patients undergoing pancreatic surveillance. Clin Cancer Res. 2018;24:2963–74.CrossRefGoogle Scholar
- 15.Illumina Support Center. 2018.. Accessed 22 Aug 2018.
- 16.Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017;100:267–80.CrossRefGoogle Scholar
- 17.Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.CrossRefGoogle Scholar
- 18.Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Current Protocols in Human Genetics. 2013;Chapter 7:Unit7.20.CrossRefGoogle Scholar
- 20.Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24.CrossRefGoogle Scholar
- 21:635–43.CrossRefGoogle Scholar
- 22–31.CrossRefGoogle Scholar
- 23–96.CrossRefGoogle Scholar
- 2441–55.CrossRefGoogle Scholar
- 25.El Jellas K, Hoem D, Hagen KG, Kalvenes MB, Aziz S, Steine SJ, et al. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival. Cancer Medicine. 2017;6:1531–40.CrossRefGoogle Scholar
- 26.Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989;342:705–8.CrossRefGoogle Scholar
- 27.Yamaguchi Y, Watanabe H, Yrdiran S, Ohtsubo K, Motoo Y, Okai T, et al. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation. Clin Cancer Res. 1999;5:1147–53.PubMedGoogle Scholar
- 28;5:e62.CrossRefGoogle Scholar
- 29.Suenaga M, Dudley B, Karloski E, Borges M, Irene Canto M, Brand RE, et al. The effect of pancreatic juice collection time on the detection of KRAS mutations. Pancreas. 2018;47:35–9.CrossRefGoogle Scholar
- 30.Allegra CJ, Rumble RB, Hamilton SR, Mangu PB, Roach N, Hantel A,Google Scholar
- 31.Witkiewicz AK, McMillan EA, Balaji U, Baek G, Lin WC, Mansour J, et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun. 2015;6:6744.CrossRefGoogle Scholar
- 32.Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321:1801–6.CrossRefGoogle Scholar
-.CrossRefGoogle Scholar
- 34.Laghi L, Orbetegli O, Bianchi P, Zerbi A, Di Carlo V, Boland CR, et al. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Oncogene. 2002;21:4301–6.CrossRefGoogle Scholar
- 35.Makohon-Moore A, Iacobuzio-Donahue CA. Pancreatic cancer biology and genetics from an evolutionary perspective. Nat Rev Cancer. 2016;16:553.CrossRefGoogle Scholar
- 36.Schirmer M, Ijaz UZ, D'Amore R, Hall N, Sloan WT, Quince C. Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform. Nucleic Acids Res. 2015;43:e37.CrossRefGoogle Scholar
- 37.Kinde I, Wu J, Papadopoulos N, Kinzler KW, Vogelstein B. Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci. 2011;108:9530–5.CrossRefGoogle Scholar
- 38.Erchinger F, Engjom T, Tjora E, Hoem D, Hausken T, Gilja OH, et al. Quantification of pancreatic function using a clinically feasible short endoscopic secretin test. Pancreas. 2013;42:1101–6.CrossRefGoogle Scholar
- 39.Mueller S, Engleitner T, Maresch R, Zukowska M, Lange S, Kaltenbacher T, et al. Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. Nature. 2018;554:62–8.CrossRefGoogle Scholar
- 40.Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature. 2016;538:378–82.CrossRefGoogle Scholar
- 41.Yokoyama S, Kitamoto S, Higashi M, Goto Y, Hara T, Ikebe D, et al. Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice. PLoS One. 2014;9:e93760.CrossRefGoogle Scholar
- 42.Hata T, Ishida M, Motoi F, Yamaguchi T, Naitoh T, Katayose Y, et al. Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: a meta-analysis. Pancreatology. 2016;16:372.As the April 1 start date of Canada's medical marijuana overhaul creeps closer, politicians and police in British Columbia are telling locals not to worry too much.
Under the new federal laws, medical pot users will no longer be able to grow marijuana for their personal use and must go through licensed commercial producers — but police and some of the province's mayors say they won't go after home grow-ops even when the federal rules become a reality.
Vancouver police said they won't be busting the city's illegal medical pot dispensaries.
The newspaper reported Wednesday that the Vancouver Police Department is aware of 29 unlicensed dispensaries operating in the city but they don't after them as long as they are only selling to those who carry a medical pot permit.
Mission Mayor Ted Adlem and Abbotsford Mayor Bruce Banman told CBC News that there are no plans to make sure home grow-ops are destroyed.
"I'm not really interested in going after a little guy that's growing for his own personal use," Adlem told the news outlet.
"That makes no sense, it is absolutely ludic